Dr Filomena Floriana Salvemini is an instrument scientist on the neutron imaging instrument DINGO.
Showing 1241 - 1260 of 1651 results
Role at ANSTO
Role at ANSTO
The dinosaur detectives: Instrument scientist who studies fossils and Dingo neutron imaging in the spotlight
Self-assembly of the bacterial flagellar motor
Funding awarded to highlight leadership opportunities for women in STEM fields
Nuclear science and the environment: threat or opportunity?
Powerful synchrotron light confirms the presence of rare diamond in stony meteorites
Australian and international researchers have used ANSTO’s Australian Synchrotron to confirm the presence of an unusual diamond found in stony meteorites.
Role at ANSTO
Role at ANSTO
Role
Australia's nuclear credentials highly regarded internationally through ANSTO
Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.
Detailed isotopic profile of groundwater in NSW can inform management of this essential resource
With world-class experts in groundwater and major contributions in this area over two decades, ANSTO completed a major project report on Improving groundwater sustainability and renewability using isotope hydrochemistry in NSW for the Department of Planning and Environment (NSW) and National Water Grid earlier in the year.
The women of nuclear stewardship science are experts in the safe use of radioactivity
Revealing the sources of Sydney’s air pollution
Fine-tuning chemistry for advanced materials
Doping with transition metals produced stability in bismuth oxide.
Fine-tuning chemistry
Doping with transition metals produced stability in bismuth oxide.
Indigenous Kakadu plum farmers attend ANSTO workshop
Indigenous Kakadu plum farmers attend workshop on use and application of the elemental fingerprint technology for indigenous bushfoods provenance.
License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.